Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00122460
Status:
COMPLETED
Last Update Posted:
2014-07-23
First Post:
2005-07-19
Brief Title:
Cetuximab Erbitux in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent andor Metastatic Squamous Cell Carcinoma of the Head and Neck EXTREME
Sponsor:
Organization:
Merck KGaA Darmstadt Germany